Diagnostic value of CD163 in cutaneous spindle cell lesions

Journal of Cutaneous Pathology

Volumn 36, Issue 8, 2009, Pages 859-864

  Pouryazdanparast, Pedram ^a   Yu, Limin ^a   Cutlan, Jonathan E ^a   Olsen, Stephen H ^a,b   Fullen, Douglas R ^a,b   Ma, Linglei ^a,b,c  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; ATYPICAL FIBROXANTHOMA; CLINICAL EVALUATION; CLINICAL FEATURE; DENDRITIC CELL; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC VALUE; EPITHELIOID CELL; FIBROXANTHOMA; HISTIOCYTE; HISTIOCYTOMA; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE XANTHOGRANULOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MELANOMA; ROSAI DORFMAN DISEASE; SKIN DEFECT; SPINDLE CELL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, SQUAMOUS CELL; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650699291     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01179.x     Document Type: Article

References (23)

1. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004 122 : 794.
2. Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 2005 29 : 617.
3. Sigel JE, Skacel M, Bergfeld WF, House NS, Rabkin MS, Goldblum JR. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2001 28 : 520.
4. Prieto VG, Lugo J, McNutt NS. Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions. J Cutan Pathol 1996 23 : 234.
5. Blessing K, Sanders DS, Grant JJ. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998 32 : 139.
6. Ribe A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol 2003 16 : 505.
7. Fullen DR, Reed JA, Finnerty B, McNutt NS. S100A6 expression in fibrohistiocytic lesions. J Cutan Pathol 2001 28 : 229.
8. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002 117 : 126.
9. Jensen K, Wilkinson B, Wines N, Kossard S. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004 31 : 57.
10. Weedon D, Williamson R, Mirza B. CD10, a useful marker for atypical fibroxanthomas. Am J Dermatopathol 2005 27 : 181. (Pubitemid 40471113)
11. Hultgren TL, DiMaio DJ. Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007 34 : 415.
12. Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature 2001 409 : 198.
13. Ochoa MT, Loncaric A, Krutzik SR, Becker TC, Modlin RL. "Dermal dendritic cells" comprise two distinct populations: CD1(+) dendritic cells and CD209(+) macrophages. J Invest Dermatol 2008 128 : 2225.
14. Zaba LC, Fuentes-Duculan J, Steinman RM, Krueger JG, Lowes MA. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 2007 117 : 2517.
15. Sachdev R, Sundram U. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa. J Cutan Pathol 2006 33 : 353.
16. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001 94 : 1.
17. Pernick NL, DaSilva M, Gangi MD, Crissman J, Adsay V. "Histiocytic markers" in melanoma. Mod Pathol 1999 12 : 1072.
18. McHugh M, Miettinen M. KP1 (CD68): its limited specificity for histiocytic tumors. Appl Immunohistochem 1994 2 : 186.
19. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 2006 30 : 521.
20. Glusac EJ, McNiff JM. Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms. Am J Dermatopathol 1999 21 : 1.
21. Zelger BG, Steiner H, Kutzner H, Maier H, Zelger B. Cellular 'neurothekeoma': an epithelioid variant of dermatofibroma? Histopathology 1998 32 : 414.
22. Longacre TA, Smoller BR, Rouse RV. Atypical fibroxanthoma. Multiple immunohistologic profiles. Am J Surg Pathol 1993 17 : 1199.
23. Ma CK, Zarbo RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992 97 : 478.